MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-13-2023
Country |
 Britain |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
128 M |
Market Cap[1] |
$ 90.8 M |
EBITDA (LTM) |
$ -94.9 M |
P/E (LTM) |
- |
P/S (LTM) |
4.4 |
EPS (LTM) |
-0.71 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Aptevo Therapeutics
APVO
|
$ 0.56 | -7.02 % | $ 155 K | Nasdaq Capital Market |  USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.03 | - | $ 234 M | Nasdaq Global Select Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.2 | 2.56 % | $ 7.7 B | Nasdaq Capital Market |  Australia |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.89 | 12.87 % | $ 482 M | Nasdaq Global Select Market | Britain |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Aptorum Group Limited
APM
|
$ 1.14 | - | $ 6.22 M | Nasdaq Global Select Market |  China |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 209.97 | 0.47 % | $ 5 B | Nasdaq Global Select Market |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
BioVie
BIVI
|
$ 1.17 | -3.31 % | $ 1.73 M | Nasdaq Capital Market | USA |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 0.18 | -15.83 % | $ 392 M | NYSE American |  Israel |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 94.82 | 0.31 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Catalyst Biosciences
CBIO
|
$ 12.23 | -1.01 % | $ 805 M | Nasdaq Capital Market | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 26.84 | -1.03 % | $ 1.3 B | Nasdaq Global Select Market | USA |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
Anika Therapeutics
ANIK
|
$ 9.5 | -0.52 % | $ 139 M | Nasdaq Global Select Market,SPB | USA |
 |
Certara
CERT
|
$ 8.87 | -0.28 % | $ 1.42 B | Nasdaq Global Select Market | USA |
 |
bluebird bio
BLUE
|
- | - | $ 546 M | Nasdaq Global Select Market,SPB | USA |
 |
Cellectis S.A.
CLLS
|
$ 4.91 | 3.47 % | $ 116 M | Nasdaq Global Market | France |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Axon Enterprise
AXON
|
$ 580.5 | -0.57 % | $ 44 B | Nasdaq Global Select Market,SPB | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |
 |
Aytu BioScience
AYTU
|
$ 2.53 | 3.27 % | $ 15.9 M | Nasdaq Capital Market | USA |
 |
AstraZeneca PLC
AZN
|
$ 92.54 | -0.39 % | $ 96.9 B | Nasdaq Global Select Market | Britain |
 |
ChromaDex Corporation
CDXC
|
- | -0.88 % | $ 598 M | Nasdaq Capital Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Burford Capital Limited
BUR
|
$ 9.21 | 1.32 % | $ 1.49 B | NYSE | Britain |
 |
Celldex Therapeutics
CLDX
|
$ 26.0 | -1.53 % | $ 1.67 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.